PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
6621817-6	1983	The GABA transaminase inhibitor gamma-acetylenic GABA increased the density of all PGO waves but was not effective in the case of PGOPCPA.	(S)-(+)-1,2-Propanediol	83-86	4-aminobutyrate aminotransferase	Homo sapiens	4-21
1275619-10	1976	The inhibitor of catechol-O-methyltransferase, tropolone, reduced the density of bially blocks the uptake of NA, was more potent on PGO(PCPA) than on PGO(1284).	(S)-(+)-1,2-Propanediol	132-135	catechol-O-methyltransferase	Felis catus	17-45
1275619-10	1976	The inhibitor of catechol-O-methyltransferase, tropolone, reduced the density of bially blocks the uptake of NA, was more potent on PGO(PCPA) than on PGO(1284).	(S)-(+)-1,2-Propanediol	150-153	catechol-O-methyltransferase	Felis catus	17-45
33877422-5	2021	Applying the CAA approach with a combination of pleconaril (capsid binder), guanidine HCl (viral 2C inhibitor), and oxoglaucine (PI4KB inhibitor) (PGO) was found to be effective in the treatment of newborn mice infected with a massive inoculum (20 MLD50) of the coxsackievirus B3 cardiotropic Woodruff or neurotropic Nancy strain.	(S)-(+)-1,2-Propanediol	147-150	phosphatidylinositol 4-kinase beta	Mus musculus	129-134
15893601-4	2005	Here, we test the hypothesis that cholinergic activation within the caudolateral PMT alters the postsynaptic excitability of the PGO network, stimulating the prolonged expression of c-fos that underlies this long-term PGO enhancement (LTPE) effect.	(S)-(+)-1,2-Propanediol	218-221	Fos proto-oncogene, AP-1 transcription factor subunit	Homo sapiens	182-187
27877775-4	2015	The PGO was prepared through a mild chemical reaction by the covalent attachment of a caged-structure organic compound, PEPA, onto GO nanosheets using toluene diisocynate (TDI) as the intermediary agent.	(S)-(+)-1,2-Propanediol	4-7	carnosine dipeptidase 2	Homo sapiens	120-124
27877775-6	2015	In our case, 7 wt% addition of PGO as one of the fillers for IFRPP composites significantly reduces its inflammability and fire hazards when compared with PEPA, by the improvement of first release rate peak (PHRR), total heat release, first smoke release rate peak (PSRR) and total smoke release, suggesting its great potential as the IFR synergist in industry.	(S)-(+)-1,2-Propanediol	31-34	carnosine dipeptidase 2	Homo sapiens	155-159
24818470-4	2014	RESULTS: A recombinant PRV expressing PCV2 ORF2 was successfully constructed, and named PGO.	(S)-(+)-1,2-Propanediol	88-91	capsid protein	Porcine circovirus 2	43-47
12749543-10	2003	Bilateral application of VIP increased the percentage of slow-wave sleep with PGO waves and rapid eye movement sleep for 5 days.	(S)-(+)-1,2-Propanediol	78-81	vasoactive intestinal peptide	Felis catus	25-28
12749543-12	2003	For both amygdaloid nuclei, we observed that VIP increased the number and modified the PGO wave pattern of occurrence during slow-wave sleep with PGO waves and during rapid eye movement sleep.	(S)-(+)-1,2-Propanediol	87-90	vasoactive intestinal peptide	Felis catus	45-48
12749543-12	2003	For both amygdaloid nuclei, we observed that VIP increased the number and modified the PGO wave pattern of occurrence during slow-wave sleep with PGO waves and during rapid eye movement sleep.	(S)-(+)-1,2-Propanediol	146-149	vasoactive intestinal peptide	Felis catus	45-48